Cargando…
3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats
Thyroid hormone mimetics are alluring potential therapies for diseases like dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and insulin resistance. Though diiodothyronines are thought inactive, pharmacologic treatment with 3,5- Diiodo-L-Thyronine (T2) reportedly reduces hepatic lipid content...
Autores principales: | Vatner, Daniel F., Snikeris, Jaclyn, Popov, Violeta, Perry, Rachel J., Rahimi, Yasmeen, Samuel, Varman T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618341/ https://www.ncbi.nlm.nih.gov/pubmed/26485433 http://dx.doi.org/10.1371/journal.pone.0140837 |
Ejemplares similares
-
Assay of Endogenous 3,5-diiodo-L-thyronine (3,5-T(2)) and 3,3′-diiodo-L-thyronine (3,3′-T(2)) in Human Serum: A Feasibility Study
por: Lorenzini, Leonardo, et al.
Publicado: (2019) -
Nonthyrotoxic Prevention of Diet-Induced Insulin Resistance by 3,5-Diiodo-L-Thyronine in Rats
por: de Lange, Pieter, et al.
Publicado: (2011) -
3,5-Diiodo-L-Thyronine Activates Brown Adipose Tissue Thermogenesis in Hypothyroid Rats
por: Lombardi, Assunta, et al.
Publicado: (2015) -
Both 3,5-Diiodo-L-Thyronine and 3,5,3′-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet
por: Senese, Rosalba, et al.
Publicado: (2017) -
3,5,3′-Triiodo-L-Thyronine- and 3,5-Diiodo-L-Thyronine- Affected Metabolic Pathways in Liver of LDL Receptor Deficient Mice
por: Moreno, Maria, et al.
Publicado: (2016)